PDHK
PDHK (pyruvate dehydrogenase kinase) is a kinase enzyme which acts to inactivate the enzyme pyruvate dehydrogenase by phosphorylating it using ATP.
Products for PDHK
- Cat.No. Product Name Information
-
GC13669
AZD7545
PDHK inhibitor,potent and selective
-
GC16795
DCA
DCA is a metabolic regulator in cancer cells' mitochondria with anticancer activity. DCA inhibits PDHK, resulting in decreased lactic acid in the tumor microenvironment. DCA increases reactive oxygen species (ROS) generation and promotes cancer cell apoptosis. DCA also works as NKCC inhibitor.
-
GC15350
Dicoumarol
NSC 17860, NSC 41834, NSC 221570
competitive NADH quinone oxidoreductase (NQO1) inhibitor -
GC50280
JX 06
NSC 402538
Potent and selective pyruvate dehydrogenase kinase (PDK) 1/2/3 inhibitor -
GC36396
KPLH1130
KPLH1130 is a specific pyruvate dehydrogenase kinase (PDK) inhibitor, blocks macrophage polarization and attenuates proinflammatory responses.
-
GC60232
M77976
M77976 is a specific ATP-competitive inhibitor of PDK4 (pyruvate dehydrogenase kinase isoforms 4), with an IC50 of 648 μM.
-
GC73738
PDK-IN-3
PDK-IN-3 (compound 1) is a potent pan inhibitor of PDK with IC50s of 109.3, 135.8, 458.7 nM and 8.67 μM against PDK 1-4, respectively.
-
GC39500
PDK4-IN-1 hydrochloride
PDK4-IN-1 hydrochloride is an anthraquinone derivative and a potent and orally active pyruvate dehydrogenase kinase 4 (PDK4) inhibitor with an IC50 value of 84 nM.
-
GC65502
TM-1
TM-1 is a potent inhibitor of pyruvate dehydrogenase kinase (PDHK1). TM-1 inhibits PDHK1 and PDHK2 with IC50s of 2.97 μM and 5.2 μM, respectively. TM-1 blocks pyruvate dehydrogenase complex (PDHC) phosphorylation, and inhibits cell proliferation.
-
GC32778
VER-246608
A pan-PDHK inhibitor